Arch Financial Statements From 2010 to 2026
| ARTHDelisted Stock | USD 0.0001 0.00 0.00% |
Check Arch Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arch Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Arch financial statements analysis is a perfect complement when working with Arch Therapeutics Valuation or Volatility modules.
Arch |
Arch Therapeutics Company Shares Outstanding Analysis
Arch Therapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Arch Therapeutics Shares Outstanding | 249.94 M |
Most of Arch Therapeutics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Arch Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Arch Therapeutics has 249.94 M of shares currently outstending. This is 38.44% higher than that of the Health Care Equipment & Supplies sector and 133.9% higher than that of the Health Care industry. The shares outstanding for all United States stocks is 56.29% higher than that of the company.
Arch Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Arch Therapeutics's current stock value. Our valuation model uses many indicators to compare Arch Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Arch Therapeutics competition to find correlations between indicators driving Arch Therapeutics's intrinsic value. More Info.Arch Therapeutics is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Arch Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Arch Therapeutics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Arch Therapeutics Financial Statements
Investors use fundamental indicators, such as Arch Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Arch Therapeutics' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company was founded in 2006 and is based in Framingham, Massachusetts. Arch Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 10 people.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Arch Pink Sheet
If you are still planning to invest in Arch Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Arch Therapeutics' history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |